3D Systems has spent years asking investors for patience. Q2 2026 finally provided a more interesting question: is the company moving from restructuring story to operating recovery?
Revenue was approximately $94.6 million, only modestly higher year over year, but the mix underneath the headline was stronger. Printer hardware sales grew more than 40% year over year, DMP 350 metal systems and SLA 825 platforms showed sharp growth, and adjusted EBITDA improved to roughly negative $0.8 million from negative $4.7 million a year earlier. First-half adjusted EBITDA was positive.
The recovery is becoming visible in the product mix
The strongest Q2 signal came from hardware. Management said DMP 350 metal-printer sales increased about 90% year over year, while SLA 825 sales grew roughly 125%. The company sold more metal printers in the first half of 2026 than in all of 2025.
This matters because 3D Systems needs fresh installed-base growth to support future materials and service revenue. A printer-heavy quarter can pressure gross margin in the short term, but a growing installed base can improve recurring economics if utilization follows.
Aerospace and healthcare are doing the heavy lifting
Healthcare remained a major source of growth, while aerospace and space applications contributed large printer orders. Management also highlighted semiconductor and data-center-related demand for metal components.
The NextDent denture platform may be particularly important because it combines equipment placement with recurring consumables. That type of revenue is strategically more attractive than one-time capital-equipment sales.
Cost reduction has bought the company time
3D Systems says its multi-quarter restructuring program has removed more than $60 million of annualized costs. Non-GAAP operating expenses fell materially year over year. This is the main reason the investment setup is more credible than it was a year ago.
But investors should not confuse cost reduction with a completed turnaround. Q3 adjusted EBITDA guidance remains negative, and the company raised equity capital in 2026. The next phase must come from profitable organic growth rather than additional financial engineering.
Subscribe to continue reading
Subscribe to get access to the rest of this post and other subscriber-only content.